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Abstract
Deficiency of serum levels of 25-hydroxyvitamin D3 has been related to increased risk of lower respiratory tract infections in
children. Respiratory syncytial virus (RSV) is a leading cause of low respiratory tract infections in infants and young children.
The neonatal calf model of RSV infection shares many features in common with RSV infection in infants and children. In the
present study, we hypothesized that calves with low circulating levels of 25-hydroxyvitamin D3 (25(OH)D3) would be more
susceptible to RSV infection than calves with high circulating levels of 25(OH)D3. Calves were fed milk replacer diets with
different levels of vitamin D for a 10 wk period to establish two treatment groups, one with high (177 ng/ml) and one with
low (32.5 ng/ml) circulating 25(OH)D3. Animals were experimentally infected via aerosol challenge with RSV. Data on
circulating 25(OH)D3 levels showed that high and low concentrations of 25(OH)D3 were maintained during infection. At
necropsy, lung lesions due to RSV were similar in the two vitamin D treatment groups. We show for the first time that RSV
infection activates the vitamin D intracrine pathway in the inflamed lung. Importantly, however, we observed that cytokines
frequently inhibited by this pathway in vitro are, in fact, either significantly upregulated (IL-12p40) or unaffected (IFN-c)i n
the lungs of RSV-infected calves with high circulating levels of 25(OH)D3. Our data indicate that while vitamin D does have
an immunomodulatory role during RSV infection, there was no significant impact on pathogenesis during the early phases
of RSV infection. Further examination of the potential effects of vitamin D status on RSV disease resolution will require
longer-term studies with immunologically sufficient and deficient vitamin D levels.
Citation: Sacco RE, Nonnecke BJ, Palmer MV, Waters WR, Lippolis JD, et al. (2012) Differential Expression of Cytokines in Response to Respiratory Syncytial Virus
Infection of Calves with High or Low Circulating 25-Hydroxyvitamin D3. PLoS ONE 7(3): e33074. doi:10.1371/journal.pone.0033074
Editor: Ralph Tripp, University of Georgia, United States of America
Received January 6, 2012; Accepted February 9, 2012; Published March 8, 2012
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: Research was conducted at at USDA research facility and all funding was provided through internal USDA research dollars. This project is an intramural
project of the UDDA/ARS National Animal Disease Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation
of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: randy.sacco@ars.usda.gov
Introduction
1,25-dihydroxyvitamin D3 (1,25(OH)2D3) has long been known
to be a primary regulator of calcium homeostasis and bone
remodeling [1]. However, recent evidence suggests additional roles
for vitamin D in hematopoietic cell differentiation and immune
function [2,3]. It is known that the nuclear vitamin D receptor
(VDR) and the enzymes responsible for activation (CYP27B1; 1a-
hydroxylase) and degradation (CYP24A1; 24-hydroxylase) of
vitamin D are expressed in subsets of immune cells. Moveover,
several aspects of immune regulation are modified by the actions
of vitamin D [2,4,5,6,7]. In fact, vitamin D-responsive elements
have been identified in the promoter region of a number of genes
with a role in immunity [8]. An examination of literature from the
last three decades of research shows that equivocal results have
been observed regarding the effect of vitamin D on pro-
inflammatory cytokine expression. In vitro studies have shown that
proinflammatory cytokine expression is increased by 1,25(OH)2D3
treatment [9,10,11] or is downregulated [12,13]. In addition,
vitamin D appears to suppress the generation of T helper 1 (TH1)
immune responses, known to be critical for clearance of many
bacterial and viral infections [14,15,16].
Respiratory infections remain a major cause of morbidity and
mortality in children world-wide [17]. Recent epidemiological
studies suggest a connection between inadequate vitamin D
concentrations and respiratory tract infections in children.
Available data indicate an association between low vitamin D
status and tuberculosis in children [18]. Moreover, deficiencies in
vitamin D have been associated with an increased incidence of
lower respiratory tract infections [19,20,21], of which respiratory
syncytial virus (RSV) is the leading cause in infants and children
worldwide [22]. In addition, the incidence of viral infections in the
pediatric population frequently peaks in winter months when
cutaneous vitamin D synthesis is at its lowest level [22,23]. Taken
together, these observations suggest a potential role for vitamin D
in modulating the immune response to respiratory infections in the
young host.
Based on available epidemiological evidence and the potential
role for vitamin D in immune regulation, studies have been
initiated to examine the ability of vitamin D to modulate the
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vitro 1,25(OH)2D3 treatment of IFN-c-activated human monocytes
enhanced the ability of these cells to inhibit Mycobacterium
tuberculosis [24,25]. In a later pivotal paper, Liu et al. [26]
demonstrated a mechanism for the inhibition of M. tuberculosis
growth by vitamin D treatment. Pathogen activation of monocytes
induces 1a-hydroxylase (1a-OHase), promoting conversion of 25-
hydroxyvitamin D3 (25(OH)D3) to the active metabolite
1,25(OH)2D3. This study further found that 1,25(OH)2D3 induces
cathelicidin expression, which in turn inhibits the growth of M.
tuberculosis in monocyte cultures. Recently, it was shown that
treatment of cultured respiratory epithelial cells with 1,25(OH)2D3
decreases RSV induction of pro-inflammatory gene expression
[27]. In spite of the reduction of antiviral IFN-b, there was no
concomitant increase in RSV replication, suggesting that provid-
ing adequate vitamin D could reduce inflammation while
maintaining antiviral activity. Although these studies suggest that
vitamin D supplementation may be beneficial to individuals with
respiratory illnesses, two recent double-blind, placebo controlled
trials in TB patients report conflicting results [28,29]. In a recent
review, Bruce et al. [30] suggests that data from several models of
infection do not provide sufficient evidence to support a role for
vitamin D in affecting the course of disease. However, it has been
recently shown in the lactating dairy cow that 25(OH)D3
administration can reduce the severity of an intramammary
infection [31]. Thus, it is clear that there is a need for additional in
vivo studies to examine the potential role of vitamin D in
modulating experimental viral respiratory infections.
We examined the influence of vitamin D status on the response
to RSV experimental challenge in calves. Calves with high or low
circulating 25(OH)D3 levels were challenged with RSV and
subsequently, lung tissue samples examined at day 7 postinfection.
We show, for the first time in vivo, that RSV infection induced
expression of the VDR and associated hydroxylase enzymes in the
lung. Importantly, gene expression levels of pro-inflammatory
cytokines were not suppressed in the presence of this induced
vitamin D regulatory network in the lung, but rather specific pro-
inflammatory cytokines were elevated in the high vitamin D group
compared to the low vitamin D group of calves.
Results
Serum 25(OH)D3 concentrations
We sought to examine the influence of vitamin D levels on the
response to RSV experimental challenge. Over a ten week period,
we were able to establish two groups of calves with differing levels of
circulating 25(OH)D3. Data in Fig. 1A shows levels of serum
25(OH)D3 at the time of infection (day 0) and at the completion of
the experiments (day 7). Calves in the high vitamin D group had
significantly (P,.001) higher circulating levels of 25(OH)D3 at the
initiation of challenge compared to the low vitamin D group
(177.3 ng/ml versus 32.5 ng/ml). The difference in 25(OH)D3
between the treatment groups was maintained over the course of the
experimental infection period with circulating levels of 189.9 ng/ml
and 26.5 ng/ml for the high vitamin D group and low vitamin D
groups at day 7 postinfection, respectively. There were no significant
differences in serum Ca
+2 (Fig. 1B), phosphorus, or Mg
+2 (data not
shown for phosphorus or Mg
+2) between the two vitamin D
treatment groups. These latter data indicate that calcium homeo-
stasis was not affected by differences in vitamin D supplementation.
Clinical signs
Rectal temperatures were recorded daily for calves in each
treatment group. There were no significant differences in body
temperature between the high vitamin D and the low vitamin D
groups (data not shown). In addition, none of the calves exhibited
a substantially prolonged elevation in body temperature following
RSV infection. Moreover, only mild coughs of short duration were
observed in the high vitamin D treatment group, with no coughing
observed in the low vitamin D treatment group. Two calves in the
high vitamin D group had increased respiration rates and reduced
feed consumption of ,24 hr duration.
Gross lesions
Gross lesions consisted of bilateral, multifocal, firm, plum-red
areas of consolidation that were of variable size and depressed
compared to the adjacent normal appearing lung (Fig. 2). Lesions
were more frequently observed in cranioventral lung lobes. On cut
surface, areas of consolidation were well delineated from adjacent
normal lung. In some cases, areas of consolidation surrounded and
divided regions of pink, hyperinflated lung. No differences in gross
lesion severity were noted between high vitamin D and low
vitamin D status calves.
Histopathological lesions
Significant microscopic lesions are shown with a representative
photomicrograph from the low vitamin D group in the left panels
and a representative photomicrograph from the high vitamin D
group in the right panels (Fig. 3A–D). It should be noted that
Figure 1. Serum 25(OH)D3 and Ca
+2 concentrations in calves at
the beginning and the termination of the bovine RSVexperi-
mental infection. Calves (n=8 per treatment group) were maintained
on diets containing 1700 IU of vitamin D/kg (low vitD) or 17,900 IU of
vitamin D/kg (high vitD) for ten weeks prior to experimental challenge.
Calves were challenged via aerosol inoculation with bovine RSV. Blood
samples were collected from each calf on the day of experimental
challenge and just prior to euthanasia. (A) Serum 25(OH)D3 was
quantified by radioimmunoassay and data shown represent the mean
6 SE. Data were analyzed using Student’s t-test. ***P,.001. (B) Serum
calcium was determined by atomic absorption spectrometry and data
shown represent the mean 6 SE.
doi:10.1371/journal.pone.0033074.g001
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The high vitamin D status group had an average lesion score of
3.5, while the low vitamin D status group had an average lesion
score of 3.9. Microscopically, interlobular septa were expanded by
clear space interpreted to be edema (Fig. 3A). Alveolar septa were
thickened due to infiltrates of macrophages, lymphocytes, and
lesser numbers of neutrophils (Fig. 3B). Intralesional bronchioles
were filled with neutrophils, sloughed epithelial cells, and necrotic
cellular debris (Fig. 3C). Bronchiolar epithelial cell necrosis
resulted in attenuation of remaining epithelial cells, or complete
loss of airway epithelium. In some bronchioles, epithelial cells
formed multinucleated syncytial cells (Fig. 3D).
Virus isolation
Nasal swabs and frozen lung tissue samples were collected for
virus isolation on the day of necropsy. In experiment 1, virus was
re-isolated from all calves in the high and low vitamin D status
groups. In experiment 2, virus was isolated from 7 out of 8 calves,
with the exception being that virus was not re-isolated from one of
the low vitamin D status group calves. Thus, high vitamin D status
did not provide an apparent advantage in regards to RSV
clearance.
VDR and hydroxylase gene expression in lung tissues
The effects of vitamin D on modulation of downstream genes
expressing vitamin D response elements (VDREs) depend on the
presence of the VDR. Therefore, gene expression of the VDR, 1a-
OHase, and 24-OHase was measured in the lungs of RSV-infected
calves with differing serum levels of 25(OH)D3. VDR was
expressed at significantly (P,.01) higher levels in sections of
lesioned lung tissue compared to non-lesioned tissue across vitamin
D treatment groups (Fig. 4A). Moreover, both 1a-OHase and 24-
OHase were strongly upregulated (P,.001) in RSV-induced lung
lesions. There was a similar gene expression of the VDR, 1a-
OHase, and 24-OHase in the non-lesioned lung samples relative
to non-infected control lung samples. Although the high vitamin D
group tended to have higher VDR gene expression (p=0.09), 1a-
OHase, and 24-OHase, there was no significant influence of
circulating serum 25(OH)D3 levels on the expression of these three
genes in lesioned lungs (Fig. 4B). These data indicate that vitamin
D intracrine regulatory pathways in the lung are activated by
RSV.
Pro-inflammatory cytokine gene expression levels in lung
tissues
RSV infection induces a wide range of inflammatory mediators
in antigen-presenting cells and respiratory epithelial cells
[32,33,34,35,36,37] and in vitro studies have suggested that
vitamin D may suppress these cytokines [38,39,40]. Based on
this information, it was intriguing to speculate that animals
provided high dietary levels of vitamin D would have reduced
pro-inflammatory cytokines in response to RSV infection
compared to animals provided low dietary levels of vitamin D.
As would be predicted, RSV infection induced elevated levels of
inflammatory cytokines, including significant IL-8, IL-12p40, and
IFN-c mRNA levels in lung lesions of RSV-infected calves
compared to levels in non-lesioned lung across vitamin D
treatment groups (Fig. 5). Further, it is of note that IL-12p40
mRNA levels were 11-fold higher in non-lesioned lung samples
from RSV-infected calves relative to levels in control lung tissue.
Interestingly, IL-12p40 was significantly elevated in calves with
high serum levels of 25(OH)D3 (Fig. 6), and contrary to in vitro
studies, neither the activation of local 1,25(OH)2D3 nor high
vitamin D status resulted in inhibition of IFN-c. Moreover, there
was a trend (p=0.1) for elevated levels of pro-inflammatory IL-8
in the high vitamin D treatment group. Thus, during experi-
mental in vivo RSV infection vitamin D supplementation does not
suppress the pro-inflammatory cytokine response in the inflamed
lung at 7 d postinfection.
Anti-inflammatory cytokine gene levels in lung tissues
TGF-b and IL-10 are known to have pronounced immuno-
modulatory and immunosuppressive function, which can be
critical in limiting tissue damage associated with immune
reactivity to pathogens at environmental interfaces [41]. In this
study, we found IL-10 gene expression was elevated more than
25-fold in both lesioned and non-lesioned sections of RSV-
infected lungs compared to control lung tissue (Fig. 7). TGF-b
gene expression tended to be higher in non-inflamed lung tissue
sections compared to inflamed lung tissue sections. In lesioned
lung sections of RSV-infected calves, IL-4 was not consistently
detected (data not shown). Further, we did not observe any
significant differences in IL-10 or TGF-b gene expression
between vitamin D treatment groups in response to RSV
infection. Our data show an induction of cytokines aimed at
reducing tissue inflammation in response to RSV infection that is
not dependent on vitamin D status.
Expression of SOCS1 and SOCS3 in lung tissues
RSV attachment (G) and nonstructural proteins (NS) have been
shown to modulate the expression of SOCS1 and SOC3 in a
mouse lung epithelial cell line [42]. On the other hand, there is
very limited data on the influence of vitamin D on SOCS
expression. Therefore, we examined lung expression of SOCS1
and 3 in response to RSV infection of calves with differing
circulating vitamin D levels (Fig. 8). SOCS1 and SOCS3 were
expressed at significantly higher levels in lesioned versus non-
lesioned lung samples from RSV-infected calves of both vitamin D
treatment groups relative to levels in control lung samples.
However, we did not observe significant differences in their
expression based on vitamin D treatment, even though there was a
tendency for higher SOCS expression in the high vitamin D
group.
Figure 2. Right lung from an RSV-infected calf at day 7 post-
infection. Note multifocal to coalescing areas of plum-red consolida-
tion in cranial and ventral aspects of right cranial and middle lobes.
Consolidated areas surround and divide foci of pale pink hyperinflated
lung (arrow). Scattered multifocal areas of consolidation are also
present in the ventral third of the right caudal lobe (arrowheads).
doi:10.1371/journal.pone.0033074.g002
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There has been much recent attention given to the role of
vitamin D in regulating host immune responses and by extension,
to the role that it might play in host resistance to infection.
Epidemiological studies have suggested an association between low
vitamin D levels and respiratory infections [19,20]. Recently,
vitamin D was found to dampen in vitro inflammatory responses of
pulmonary epithelial cells to RSV infection without a concomitant
increase in viral replication [27]. Thus, it is of interest to determine
whether vitamin D supplementation could be effective against an
in vivo RSV infection. In this study, we have shown that pro-
inflammatory cytokine responses to respiratory syncytial virus
infection are, in fact, elevated in the lungs of calves receiving high
levels of dietary vitamin D supplementation compared to those
receiving low levels of dietary vitamin D. However, in spite of the
higher levels of pro-inflammatory cytokines, we did not observe
any differences in severity of lung lesions between the vitamin D
treatment groups at a time point chosen when there is significant
lung involvement in ruminant models of RSV infection [43,44].
We believe that there are several major advantages to the
bovine model system employed in the present study for examining
the influences of vitamin D supplementation on RSV infection.
Naturally occurring RSV infection in young ruminants mimics
pathogenesis and lesions observed in RSV infection of infants and
children [43,45,46,47]. As is the case for humans, neonatal calves
Figure 3. Histological lesions observed in lung of high and low vitamin D treatment groups of calves after experimental infection
with bovine RSV. Calves with low or high circulating 25(OH)D3 were challenged via aerosol with bovine RSV. On day 7 post-infection, samples of
lung were collected for histological evaluation. A representative image from a single calf for each treatment group (low vitD left panels; high vitD
right panels) is shown. (A) Moderate interstitial thickening and wide interlobular septae due to edema. Original magnification, 46.( B) Alveolar septae
are thickened due to cellular infiltrates found to be macrophages, lymphocytes and lesser numbers of neutrophils when viewed at higher
magnification. Original magnification, 206.( C) Bronchioles are filled with neutrophils, sloughed epithelial cells, and necrotic cell debris. Original
magnification, 206.( D) There is partial to complete loss of bronchiolar epithelial cells with attenuation of remaining cells. In some bronchioles,
epithelial cells form multinucleated syncytial cells (arrows). Original magnification, 406.
doi:10.1371/journal.pone.0033074.g003
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addition, alveolar development begins prenatally in humans and
ruminants, whereas mice have postnatal alveolar development
[48,49]. Finally, calves provide a valuable model for estimating the
vitamin D requirements for an adequately functioning human
immune system. A concern of the mouse model is that the vitamin
D requirements of the mouse differ from those of humans and
cattle. At least a partial explanation for these differences is likely
due to the fact mice are nocturnal and do not rely on endogenous
synthesis of vitamin D3 in the skin to assure vitamin D adequacy
[26].
Our data showing that established differences in circulating
25(OH)D3 levels did not alter gross or microscopic lesions induced
by RSV infection adds to the conflicting body of literature on the
potential for vitamin D to modify the outcome of an experimental
infection. There are several previous studies that have examined
the relationship between vitamin D and experimental infection by
utilizing mouse models with targeted disruptions of vitamin D
signaling pathways or providing vitamin D supplementation. In
response to Listeria moncytogenes infection, VDR
2/2 mice were able
to clear a primary or secondary infection, although kinetics was
delayed in the absence of the VDR [50]. Similarly, VDR knockout
mice showed normal clearance of Leishmania major [51]. By
contrast, vitamin D-deficient mice were more susceptible to
Mycobacterium bovis infection compared to vitamin D-sufficient mice
[52]. Treatment of mice with 1,25(OH)2D3 did not alter clearance
of Candida albicans or herpes simplex virus [53]. On the other hand,
we have recently shown that treatment with 25(OH)D3 reduced
the severity of an acute bacterial infection in the bovine mammary
gland [31]. It is plausible that the role of vitamin D in modulating
the response to infection will differ depending on the nature of the
inciting pathogen as well as which functional division of the
immune system is primarily responsible for disease resolution.
Vitamin D is likely to have complex effects on pulmonary cell
biology and lung immunity. It is known that respiratory epithelial
cells express high baseline levels of activating 1a-OHase and low
levels of catabolizing 24-OHase [54]. We provide evidence that
extarenal induction of 1a-OHase exists in the lung during
experimental RSV infection. Extrarenal production of 1a-OHase
may be stimulated by cytokines such as IL-1 and IFN-c [55,56],
cytokines we show are upregulated in lung lesions of RSV-infected
calves. Upregulation of genes involved in vitamin D regulation in
the infected lung has major implications because it allows for local
control of 1,25(OH)2D3 synthesis. In addition, induction of 1a-
OHase and VDR expression would subsequently enhance the
expression of multiple downstream genes containing VDREs in
their promoter region [57].
There exist similarities between cattle and humans in regards to
vitamin D metabolism and immune function, such that cattle
should be considered a useful model for examination of vitamin D
requirements for proper immune function in humans. The
substrate for 1a-OHase is 25(OH)D3, so the production of
bioactive vitamin D depends on the availability of its substrate.
Circulating concentrations of 25(OH)D3 depend on exposure to
sunlight and dietary intake of vitamin D [58]. 25(OH)D3 serum
levels in cattle typically range from 20 to 50 ng/ml [59]. In the
Figure 4. Nuclear VDR and hydroxylase gene expression levels in lung tissues of calves following bovine RSV experimental
infection. (A) Vitamin D receptor (VDR), CYP27B1 (1a-OHase), or CYP24A1 (24-OHase) mRNA levels in lesioned or non-lesioned lung samples from
bovine RSV-infected calves irrespective of vitamin D treatment (n=16). (B) Vitamin D receptor (VDR), CYP27B1 (1a-OHase), or CYP24A1 (24-OHase)
mRNA levels in lesioned lung samples from bovine RSV-infected calves with low (n=8) or high (n=8) circulating 25(OH)D3 levels. The amount of each
target gene was determined by quantitative real-time PCR with normalization to RPS9. DDCt values 6 SE were transformed (2
2DDCt) and data are
presented as the target gene expression relative to control lung samples (n=4). Statistical analysis was performed using Student’s t-test. DDCt values
were used in the analysis of relative gene expression. **P,.01,***P,.001.
doi:10.1371/journal.pone.0033074.g004
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vitamin D group at the initiation of the RSV challenge experiment
were above levels (20 ng/ml) considered adequate for calcium
homeostasis and levels (30 ng/ml) currently suggested to be
sufficient for proper immune function in humans [58]. However,
at day 7 following RSV infection, serum levels of 25(OH)D3 were
slightly below 30 ng/ml in the low vitamin D group. In spite of the
differing levels of 25(OH)D3, lung lesions induced by RSV infection
in calves were similar in the two vitamin D treatment groups. It is
unclear at present whether the higher induction of pro-inflamma-
tory cytokines would be protective or detrimental in resolution of
RSV infection in the high vitamin D treatment group, since in this
study we did not examine later time points of disease resolution.
Previously, we and othershave shown that RSV infectioninduces
inflammatory cytokines in antigen-presenting cells and respiratory
epithelial cells, the kinetics of which differs between cytokines
[32,33,34,35,36,37]. For example, we found peak induction of IL-
1b mRNA in antigen-presenting cells occurs on day 3 post-infection
in the neonatal ruminant RSV model [36]. In the present study, we
show a significant upregulation of the pro-inflammatory cytokine
IL-8inlesioned lungsofRSV-infected calveson day7 postinfection.
Importantly, our results fit well with data showing that IL-8 is
elevated in the respiratory tract of children with RSV brochiolitis
[60,61]. Rodents lack a bona fide homologue of IL-8, although mice
have what are considered to be functional homologues, CXCL1
(GRO/KC), CXCL2 (MIP-2) and CXCL5-6 (LIX), that belong to
the same major cluster of chemokines [62]. It is therefore evident
that the neonatal calf model can prove useful as an in vivo platform
for future exploration into pathways that specifically regulate IL-8
responses to RSV infection.
Critical to the induction of inflammatory cytokines by the innate
immune system are pattern recognition receptors (PRRs) that
recognize evolutionarily conserved pathogen-associated molecular
patterns, such as nucleic acids. Recognition of viral nucleic acids
involves two distinct PRRs, retinoic acid inducible gene-I (RIG-I)-
like RNA helicases and toll-like receptors (TLRs). Among multiple
TLR isoforms expressed in airway epithelial cells, TLR3 is one of
the most abundant [63]. It has been shown that RSV induces
cytokine/chemokine production in airway epithelial cells via
signaling through TLR3 and RIG-I, which are linked to distinct
pathways controlling NF-kB activation [64,65]. The results of
several in vitro studies have suggested that vitamin D may suppress
the levels of inflammatory molecules that are induced via TLR
signaling in multiple cell types [66,67,68,69]. In addition, vitamin D
was found to decrease NF-kB-induced inflammatory mediators in
airway epithelial cells infected with RSV [27]. In contrast,
additional reports have suggested inflammatory molecules induced
in response to TLR agonists are not suppressed [7,9,10,11]. Data
from our experimental RSV infection model indicates that in lungs
of calves with higher circulating 25(OH)D3, IL-12p40 was
significantly upregulated compared to that in lungs of calves with
lower circulating 25(OH)D3. Furthermore, we show that IL-8 and
IFN-c, were not inhibited in calves with high circulating 25(OH)D3
compared to calves with low 25(OH)D3. Taken together, our data
indicate vitamin D did not suppress cytokines that can be induced
via PRR ligation in response to RSV infection.
Cytokine secretion and immune responses are tightly controlled
by an intricate balance between positive and negative regulatory
signals that are delivered following an antigenic encounter. The
recently described SOCS proteins act in a classic negative
Figure 5. Pro-inflammatory cytokine gene expression levels in lung tissues of calves following bovine RSV experimental infection.
Inflammatory cytokine RNA levels in lesioned or non-lesioned lung samples from bovine RSV-infected calves irrespective of vitamin D treatment
(n=16). The amount of each target gene was determined by quantitative real-time PCR with normalization to RPS9. DDCt values 6 SE were
transformed (2
2DDCt) and data are presented as the expression relative to control lung samples (n=4). Statistical analysis was performed using
Student’s t-test. DDCt values were used in the analysis of relative gene expression. *P,.05, **P,.01.
doi:10.1371/journal.pone.0033074.g005
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known that cytokines can, in fact, induce the expression of SOCS
proteins. Moreover, a previous in vitro study has shown that RSV
can modulate the expression of SOCS1 and SOCS3 [42]. We
provide the first in vivo evidence that RSV infection induced
significantly higher levels of SOC1 and SOCS3 expression in the
inflamed lung. However, the two vitamin D treatment groups did
not differ significantly in the levels of SOCS1 or SOCS3 gene
expression. These data are indicative of a compensatory host tissue
mechanism for regulating inflammatory responses that may be
independent of vitamin D levels.
In conclusion, the major findings of the present study are that
RSV activates the vitamin D intracrine pathway in the lesioned
lung, and while vitamin D status does have an immunomodulatory
role, there was no significant impact on the pathogenesis during
the early phases of RSV infection. Examination of the potential
effects of vitamin D status on RSV disease resolution will require
additional longer term studies in calves with immunologically
sufficient and deficient circulating 25(OH)D3 levels.
Materials and Methods
Calves
In two experiments, sixteen neonatal Holstein calves (n=8/
experiment) were randomly assigned to milk replacer diets with
differing levels of vitamin D that resulted in two groups of calves
(n=4/group/experiment) which had high or low levels of
circulating 25(OH)D3. Prior to this study, calves were healthy and
were not vaccinated against bovine RSV. Calves were maintained
on liquid milk replacer diets (Animix, LLC, Juneau, WI) containing
1700 IU of vitamin D/kg or 17,900 IU of vitamin D/kg for ten
weeks prior to experimental challenge. A typical milk replacer diet
would contain 11,000 IU/kg. The National Animal Disease Center
Institutional Animal Care and Use Committee approved all animal
procedures conducted in this study (ACUP #ARS-3993).
Serum chemistries
Blood samples were collected from each calf on the day of
experimental challenge and just prior to euthanasia. Serum
25(OH)D3 was quantified by radioimmunoassay as previously
described [71]. Intra- and interassay coefficients of variation were
9.4% and 16.3%, respectively.
Serum calcium concentrations were determined by atomic
absorption spectrometry (Perkin-Elmer, Norwalk, CT) using the
method of Cali et al. [72]. Briefly, serum samples were prepared
and measured in duplicate by diluting 100 ml of sample in 5 ml of
0.1% lanthanum oxide solution. A combined Ca
+2 and Mg
+2 lamp
was used such that serum Mg
+2 concentration was also
determined. Plasma Ca
+2 and Mg
+2 concentrations were deter-
mined at 422.7 and 185.3 nm, respectively.
Figure 6. Pro-inflammatory cytokine gene expression levels in lesioned lung tissues of calves with high or low circulating 25(OH)D3
following bovine RSV experimental infection. Inflammatory cytokine mRNA levels in lesioned lung samples from bovine RSV-infected calves
with low (n=8) or high (n=8) circulating 25(OH)D3 levels. The amount of each target gene was determined by quantitative real-time PCR with
normalization to RPS9. DDCt values 6 SE were transformed (2
2DDCt) and data are presented as the target gene expression relative to control lung
samples (n=4). Statistical analysis was performed using Student’s t-test. DDCt values were used in the analysis of relative gene expression. *P,.05.
doi:10.1371/journal.pone.0033074.g006
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dures modified from Parekh and Jung [73], as validated in our
laboratory. Briefly, serum (125 ml) was precipitated by acidification
with 1 ml of molybdic-trichloroacetic acid solution. After mixing
and equilibration for 5 min, this solution was centrifuged (10006
g) and 100 ml of supernatant was transferred in duplicate to a 96-
well microtiter plate (Costar Corning, Acton, MA). Finally, 150 ml
of p-phenylenediamine reagent (prepared by dissolving 1 g of p-
phenylenediamine dihydrochloride in 100 ml of 5% Na2S2O5
solution) was added to all wells and the plate was incubated for
20 min at room temperature. Serum phosphorus was determined
at a wavelength between 690 and 560 nm using a Thermo Max
tunable microplate reader spectrophotometer (Molecular Devices,
Sunnyvale, CA).
RSV challenge model
Bovine RSV strain 375 used for inoculation of calves has been
described in our previous studies [36,43]. The inoculum was
prepared from virus stock re-isolated from the lung of an infected
animal and passaged less than 4 times on bovine turbinate cells.
When 90% of virus-induced cytopathic effect was visible, flasks
were frozen, and thawed twice. Media were pooled and
centrifuged to remove cellular debris. Supernatants were filtered,
aliquoted, and stored at 280uC. One aliquot was used to
determine the tissue culture infective dose (TCID50/ml) by
standard plaque assay.
The bovine RSV aerosol challenge model used was similar to
that previously described by Woolums et al. [44]. Briefly, the
challenge inoculum was delivered by nebulization into a mask
covering the nostrils and mouth. The nebulization apparatus
consisted of a compressed air tank, a jet nebulizer, and a mask
(Trudell Medical International, London, Ontario, Canada). A
rubber gasket was added to the mask, which sealed it securely to
the muzzle. Compressed air (25 lb/in
2) was used to jet nebulize
the challenge inoculum directly into a holding reservoir. Upon
inspiration, the nebulized inoculum was inhaled through a one-
way valve into the mask and directly into the nostrils. Each calf
received a 5 ml challenge inoculum containing approximately 10
4
TCID50/ml of bovine RSV strain 375 during the nebulization
period of 10–15 min.
Clinical evaluation
Calves were examined daily for clinical signs. Rectal temper-
ature, respiratory rate, evidence of ocular or nasal discharge,
cough, dyspnea, and appetite were evaluated and recorded for
each calf.
Figure 7. Anti-inflammatory cytokine gene expression levels in lung tissues of calves following bovine RSV experimental infection.
(A) Anti-inflammatory cytokine mRNA levels in lesioned or non-lesioned lung samples from bovine RSV-infected calves irrespective of vitamin D
treatment (n=16). (B) Anti-inflammatory cytokine mRNA levels in lesioned lung samples from bovine RSV-infected calves with low (n=8) or high
(n=8) circulating 25(OH)D3 levels. The amount of each target gene was determined by quantitative real-time PCR with normalization to RPS9. DDCt
values 6 SE were transformed (2
2DDCt) and data are presented as the target gene expression relative to control lung samples (n=4). Statistical
analysis was performed using Student’s t-test. DDCt values were used in the analysis of relative gene expression.
doi:10.1371/journal.pone.0033074.g007
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Calves were euthanized at day 7 post-inoculation using IV
sodium pentobarbital. The thorax was opened and the lungs
evaluated for gross lesions. The lungs were then removed from the
thorax for subsequent tissue collection. Sections of lung were
collected for histopathological evaluation. Tissues were fixed by
immersion in 10% neutral buffered formalin for 24 h and
transferred to 90% ethanol. Samples were processed by routine
paraffin-embedment processing techniques, 5 mm sections were
cut and stained with hematoxylin and eosin. Microscopic lesions
were evaluated by a pathologist without knowledge of vitamin D
treatment group assignment. The severity of microscopic lesions
was evaluated by examining sections to confirm the presence of
any or all of the following changes: 1) atelectasis; 2) alveolar septal
expansion due to cellular infiltrates; 3) pulmonary edema,
evidenced by expansion of interlobular septae; 4) hyperplasia of
bronchial associated lymphoid tissue (BALT) characterized by
cuffing of bronchi with lymphoid follicles; 5) intra-alveolar and
intra-bronchiolar infiltrates of neutrophils, macrophages or
lymphocytes 6) attenuation of airway (bronchi and bronchioles)
epithelium due to necrosis and loss of epithelial cells; and 7)
presence of syncytia. Most severely affected sections were
characterized by the presence of all 7 lesions (score=7), while
the least severely affected sections contained only one of the lesions
(score=1).
Virus Isolation
Nasal swabs and samples of snap-frozen lung that were
collected from each calf at necropsy were processed for virus
isolation as follows. Nasal swabs placed in PBS were vortexed,
samples clarified by centrifugation (8006 g,1 5 m i n ,4 uC),
supernatants harvested, and stored at 280uC. Frozen lung tissue
was disrupted by grinding with a mortar and pestle. A 10%
suspension of the lung homogenate was made in minimal
essential medium (MEM). The suspension was clarified by
centrifugation (10006g,3 0m i n ,4 uC), the supernatant harvested
and stored at 280uC. Supernatants from nasal swabs or lung
homogenates were inoculated onto confluent monolayers of
Madin-Darby Bovine Kidney cells and incubated for 90 min at
37uCw i t h5 %C O 2. After incubation, the inoculum was
aspirated and fresh supplemented medium was added. Cultures
were incubated at 37uC, 5%CO2 and daily observations for
cytopathic effect were conducted and recorded for 7 days
following inoculation of cells.
Figure 8. SOCS1 and SOCS3 gene expression in lung tissues of calves following bovine RSV experimental infection. (A) Suppressors
of cytokine signaling (SOCS) 1 or SOCS3 mRNA levels in lesioned or non-lesioned lung samples from bovine RSV-infected calves irrespective of
vitamin D treatment (n=16). (B) Suppressors of cytokine signaling (SOCS) 1 or SOCS3 mRNA levels in lesioned lung samples from bovine RSV-infected
calves with low (n=8) or high (n=8) circulating 25(OH)D3 levels. The amount of each target gene was determined by quantitative real-time PCR with
normalization to RPS9. The relative amount of each target gene was determined using the 2
2DDCt method. DDCt values 6 SE were transformed
(2
2DDCt) and data are presented as the target gene expression relative to control lung samples (n=4). Statistical analysis was performed using
Student’s t-test. DDCt values were used in the analysis of relative gene expression. *P,.05.
doi:10.1371/journal.pone.0033074.g008
Vitamin D Impacts Immunity to RSV in Calves
PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e33074Real-time PCR
Lung samples from a representative gross lesion and non-
lesioned tissue from each calf were collected and stored in
RNAlaterH (Invitrogen, Life Technologies, Carlsbad, CA). RNA
was isolated from lung tissue samples using the Trizol Reagent
(Invitrogen, Life Technologies) according to manufacturer’s
instructions. In addition, RNA was obtained from lung sections
of 4 non-infected, control calves. The RNA concentration in each
sample was determined using a NanoDrop 2000 spectrophotom-
eter (Thermo Scientific, Wilmington, DE). RNA (300 ng per
sample) was DNase-treated and cDNA synthesized using random
primers according to the manufacturer’s instructions (Invitrogen,
Life Technologies). SYBR Green-based real-time PCR was
performed on a 7300 Real-Time PCR System (Applied
Biosystems, Life Technologies, Carlsbad, CA). The following
amplification conditions were used: 95uC for 10 min, followed by
40 cycles at 95uC for 15 s and 60uC for 1 min, and a final
dissociation step. Each reaction contained 10 mlS Y B RG r e e n
master mix (Applied Biosystems), 1.25 mle a c ho f1 0mM forward
and reverse primers (Table 1), 5.5 mld H 20, and 2 mlo fc D N A .
Relative gene expression was determined using the 2
2DDCt
method [74]. RPS9 was used as the reference gene as previously
described [6,7].
Statistical analysis
Body temperatures were analyzed using a repeated measures
ANOVA (Prism, GraphPad, La Jolla, CA). Comparisons of serum
25(OH)D3 levels in the high and low vitamin D groups were
conducted using a two-tailed Student’s t test (Prism, GraphPad).
DDCt values were used in the statistical analyses of relative gene
expression. Analyses to compare high versus low vitamin D
treatment groups or lesioned versus non-lesioned lung samples
were performed using a two-tailed Student’s t-test statistic (Prism,
GraphPad). DDCt values 6 SE were transformed (2
2DDCt) and are
shown as the expression relative to control lung samples [74].
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Table 1. Primers used in the present study.
Gene (alternate name) Accession number
1 Strand Sequence (59-39)
2
IL-1b X54796 Forward
Reverse
ATGGGTGTTCTGCATGAG
AAGGCCACAGGAATCTTG
IL-4 NM_173921.2 Forward
Reverse
GCGGACTTGACAGGAATCTC
GCGTACTTGTGCTCGTG
IL-6 NM_173923.2 Forward
Reverse
CTGAAGCAAAAGATCGCAGATCTA
CTCGTTTGAAGACTGCATCTTCTC
IL-8 X78306 Forward
Reverse
AAGCTGGCTGTTGCTCTC
GGCATCAGAAGTTCTGTACTC
IL-10 NM_174088.1 Forward
Reverse
TTACCTGGAGGAGGTGATG
GTTCACGTGCTCCTTGATG
IL-12p40 AF004024 Forward
Reverse
AAGTCACATGCCACAAGG
CACTCCAGAATGAGCTGTAG
IFN-c NM_174088.1 Forward
Reverse
AGAATCTCTTTCGAGGCCGGAG
TATTGCAGGCAGGAGGACCATTAC
TGF-b NM_001166068.1 Forward
Reverse
CTGAGCCAGAGGCGGACTAC
TGCCGTATTCCACCATTAGCA
TNF-a NM_173966.2 Forward
Reverse
CGGGGTAATCGGCCCCCAGA
GGCAGCCTTGGCCCCTGAAG
SOCS1 CB460055 Forward
Reverse
CACAGCAGAAAAATAAAGCCAGAGA
CTCGTACCTCCTACCTCTTCATGTT
SOCS3 NM_174466 Forward
Reverse
GGCCACTCTCCAACATCTCTGT
TCCAGGAACTCCCGAATGG
VDR NM_001167932 Forward
Reverse
AGCCACCGGCTTCCATTTCA
AACAGCGCCTTCCGCTTCAT
1a-OHase (CYP27B1) NM_001192284 Forward
Reverse
TGGACCAGATGTTTTGCATTCGC
TTCTAGACTGGTTCCTCATGGCT
24-OHase (CYP24A1) NM_001191417 Forward
Reverse
GAAGACTGGCAGAGGGTCAG
CAGCCAAGACCTCGTTGATT
RPS9 NM_001101152 Forward
Reverse
CGCCTCGACCAAGAGCTGAAG
CTCCAGACCTCACGTTTGTTCC
1Accession numbers from NCBI database http://www.ncbi.nlm.nih.gov.
2Primer sequences have been published previously [6,7,36,37] or were designed in our laboratory.
doi:10.1371/journal.pone.0033074.t001
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